Literature DB >> 832666

Inhibition by PGE2 and by phenylephrine of catecholamine release from human adrenal in vitro.

P Boonyaviroj, Y Gutman.   

Abstract

The release of catecholamines from human adrenal was studied by in vitro incubation of slices. Catecholamine release was significantly inhibited by the addition of either phenylephrine (10(-5) M) or PGE2 (10(-7) M) to the incubation medium. The similarity of these modulating actions to those found in rat adrenal is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832666     DOI: 10.1016/0014-2999(77)90373-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Activation of adrenal medulla adenylate cylase and catecholamine secretion.

Authors:  Y Gutman; P Boonyaviroj
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

2.  Reversal of prostaglandin E2 effect on adrenal catecholamine release after hypophysectomy.

Authors:  P Boonyaviroj; G Feuerstein; Y Gutman
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

3.  Effects of indomethacin on endocrine responses and nitrogen loss after surgery.

Authors:  T Asoh; C Shirasaka; I Uchida; H Tsuji
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

4.  Opposite effect of PGE2 on cAMP levels in human adrenal medulla and pheochromocytoma.

Authors:  P Boonyaviroj; Y Gutman
Journal:  Experientia       Date:  1977-08-15

5.  Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland.

Authors:  A R Wakade
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

6.  Chemical sympathectomy abolishes the increase in blood pressure of linoleic acid deficient fed rats induced by salt loading.

Authors:  P Hoffmann; C Taube; K Pönicke; W Förster; L Somova; V Orbetzova; D Kiprov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.